The U.S. Centers for Disease Control and Prevention (CDC) has updated the number of people who have fallen ill from consuming “Diamond Shruumz” food products to 26.
Diamond Shruumz products are sold in stores and online at retailers, including ones selling hemp-derived (e.g., cannabidiol [CBD], delta-8 tetrahydrocannabinol [THC]) and smoke/vape products.
By June 11, poison centers received complaints of adverse effects from 12 patients seeking medical attention after consuming Diamond Shruumz items. The adverse effects included muscle rigidity, abnormal blood pressure, skin flushing, tremor, and gastrointestinal effects. Ten patients were hospitalized, with several of them requiring mechanical ventilation, intubation, and ICU care.
The FDA has been in contact with the company about potentially issuing a voluntary recall. These discussions are still “ongoing,” the agency said. “Individuals should not eat, sell, or serve any flavors of Diamond Shruumz brand chocolate bars, cones, or gummies, and should discard products that have been purchased,” the CDC said.
The agencies are also looking at whether other products from the company have similar adverse effects. The CDC pointed out that common terms for advertising these types of products include “microdosing,” “functional mushrooms,” and “adaptogens.” For instance, the Diamond Shruumz chocolate bars under investigation are advertised as a “microdosing” product.
“Legal mushrooms like those we use her.